Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis

Lemarquis A, Campbell T, Aranda-Guillén M, Hennings V, Brodin P, Kämpe O, Blennow K, Zetterberg H, Wennerås C, Eriksson K, Landegren N, Bryceson Y, Berg S, Ekwall O

J Allergy Clin Immunol 148 (1) 96-98 [2021-07-00; online 2021-07-00]

Type: Other

PubMed 33892926

DOI 10.1016/j.jaci.2021.03.034

Crossref 10.1016/j.jaci.2021.03.034

pii: S0091-6749(21)00556-X
pmc: PMC8051851


Publications 7.1.2